Join
Live feed
·
INSIDERFilingvia Quantisnow
Amylyx Pharmaceuticals Inc. logo

Co-Chief Executive Officer Cohen Joshua B was granted 180,118 shares, increasing direct ownership by 6% to 3,376,770 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AMLX· Amylyx Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMLX (Amylyx Pharmaceuticals Inc.) and more on Quantisnow.